Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EW Edwards Lifesciences	$70.90 -0.4%	$71.49	$58.93 ▼ $95.73	$41.68B	1.12	4.79 million shs	4.51 million shs
HOLX Hologic	$61.32 -1.6%	$65.24	$60.34 ▼ $84.67	$13.76B	0.97	1.80 million shs	1.11 million shs
IDXX IDEXX Laboratories	$415.87 -1.6%	$437.07	$398.50 ▼ $548.88	$33.71B	1.39	579,598 shs	470,167 shs
RMD ResMed	$219.85 -1.2%	$233.70	$172.19 ▼ $263.05	$32.29B	0.74	999,116 shs	542,418 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EW Edwards Lifesciences	0.00%	+0.63%	-1.00%	-4.50%	-25.81%
HOLX Hologic	0.00%	-0.24%	-3.26%	-15.15%	-21.34%
IDXX IDEXX Laboratories	0.00%	-1.22%	-4.86%	+0.76%	-22.98%
RMD ResMed	0.00%	+0.04%	-5.77%	-4.20%	+11.02%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EW Edwards Lifesciences	4.6112 of 5 stars	3.2	3.0	0.0	4.0	3.0	2.5	2.5
HOLX Hologic	4.8018 of 5 stars	4.2	3.0	0.0	4.3	2.8	1.7	2.5
IDXX IDEXX Laboratories	4.2538 of 5 stars	3.4	2.0	0.0	3.7	3.1	2.5	1.3
RMD ResMed	4.5071 of 5 stars	3.3	1.0	3.3	4.5	3.0	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EW Edwards Lifesciences	2.40	Hold	$79.95	12.77% Upside
HOLX Hologic	2.41	Hold	$84.62	37.99% Upside
IDXX IDEXX Laboratories	2.80	Moderate Buy	$533.75	28.35% Upside
RMD ResMed	2.67	Moderate Buy	$249.73	13.59% Upside

Current Analyst Ratings Breakdown

Latest HOLX, EW, IDXX, and RMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/19/2025	RMD ResMed	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$280.00
3/5/2025	RMD ResMed	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy
3/5/2025	RMD ResMed	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$250.00 ➝ $240.00
3/4/2025	HOLX Hologic	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$80.00 ➝ $70.00
3/3/2025	HOLX Hologic	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
2/13/2025	EW Edwards Lifesciences	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$88.00 ➝ $90.00
2/13/2025	EW Edwards Lifesciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$68.00 ➝ $71.00
2/12/2025	EW Edwards Lifesciences	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
2/12/2025	EW Edwards Lifesciences	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$85.00 ➝ $85.00
2/12/2025	EW Edwards Lifesciences	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$70.00 ➝ $73.00
2/12/2025	EW Edwards Lifesciences	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$75.00 ➝ $73.00

(Data available from 3/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EW Edwards Lifesciences	$5.44B	7.66	$2.62 per share	27.04	$11.08 per share	6.40
HOLX Hologic	$4.04B	3.41	$5.25 per share	11.69	$21.27 per share	2.88
IDXX IDEXX Laboratories	$3.90B	8.65	$10.42 per share	39.92	$19.48 per share	21.35
RMD ResMed	$4.93B	6.55	$8.71 per share	25.23	$35.77 per share	6.15

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EW Edwards Lifesciences	$4.17B	$6.97	10.17	25.78	4.82	72.93%	19.40%	14.37%	4/24/2025 (Estimated)
HOLX Hologic	$789.50M	$3.17	19.34	13.27	2.14	18.42%	19.72%	10.94%	5/1/2025 (Estimated)
IDXX IDEXX Laboratories	$887.87M	$10.67	38.98	30.62	3.41	22.78%	55.82%	26.48%	5/7/2025 (Estimated)
RMD ResMed	$1.02B	$8.47	25.96	21.22	1.53	25.34%	26.17%	18.60%	4/24/2025 (Estimated)

Latest HOLX, EW, IDXX, and RMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/24/2025	N/A	EW Edwards Lifesciences	$0.60	N/A	N/A	N/A	$1.40 billion	N/A
4/24/2025	N/A	RMD ResMed	$2.37	N/A	N/A	N/A	$1.28 billion	N/A
2/11/2025	Q4 2024	EW Edwards Lifesciences	$0.55	$0.59	+$0.04	$0.65	$1.36 billion	N/A
2/5/2025	Q1 2025	HOLX Hologic	$1.02	$1.03	+$0.01	$0.87	$1.02 billion	N/A
1/30/2025	Q2 2025	RMD ResMed	$2.29	$2.43	+$0.14	$2.34	$1.27 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
HOLX Hologic	N/A	N/A	N/A	N/A	N/A
IDXX IDEXX Laboratories	N/A	N/A	N/A	N/A	N/A
RMD ResMed	$2.12	0.96%	+7.63%	25.03%	13 Years

Latest HOLX, EW, IDXX, and RMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/30/2025	RMD ResMed	quarterly	$0.53	0.9%	2/13/2025	2/13/2025	3/20/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EW Edwards Lifesciences	0.06	3.46	2.89
HOLX Hologic	0.52	3.49	2.78
IDXX IDEXX Laboratories	0.28	1.31	0.95
RMD ResMed	0.13	3.33	2.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EW Edwards Lifesciences	79.46%
HOLX Hologic	94.73%
IDXX IDEXX Laboratories	87.84%
RMD ResMed	54.98%

Insider Ownership

Company	Insider Ownership
EW Edwards Lifesciences	1.29%
HOLX Hologic	1.88%
IDXX IDEXX Laboratories	2.11%
RMD ResMed	0.71%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EW Edwards Lifesciences	17,300	587.90 million	582.19 million	Optionable
HOLX Hologic	6,940	224.39 million	220.17 million	Optionable
IDXX IDEXX Laboratories	10,800	81.06 million	80.16 million	Optionable
RMD ResMed	8,160	146.87 million	145.82 million	Optionable

HOLX, EW, IDXX, and RMD Headlines

Recent News About These Companies

Mawer Investment Management Ltd. Increases Stake in ResMed Inc. (NYSE:RMD)

March 31 at 6:40 AM | marketbeat.com

Martin Currie Ltd. Has $26.27 Million Stake in ResMed Inc. (NYSE:RMD)

March 31 at 6:39 AM | marketbeat.com

10,005 Shares in ResMed Inc. (NYSE:RMD) Acquired by New Age Alpha Advisors LLC

March 31 at 4:45 AM | marketbeat.com

NEOS Investment Management LLC Grows Holdings in ResMed Inc. (NYSE:RMD)

March 31 at 4:36 AM | marketbeat.com

Maridea Wealth Management LLC Invests $481,000 in ResMed Inc. (NYSE:RMD)

March 30 at 6:21 AM | marketbeat.com

Horizon Investment Services LLC Invests $1.61 Million in ResMed Inc. (NYSE:RMD)

March 30 at 6:06 AM | marketbeat.com

Elo Mutual Pension Insurance Co Grows Stake in ResMed Inc. (NYSE:RMD)

March 30 at 5:09 AM | marketbeat.com

ResMed Inc. (NYSE:RMD) Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

March 30 at 4:58 AM | marketbeat.com

Korea Investment CORP Increases Position in ResMed Inc. (NYSE:RMD)

March 30 at 4:50 AM | marketbeat.com

denkapparat Operations GmbH Invests $313,000 in ResMed Inc. (NYSE:RMD)

March 29 at 6:57 AM | marketbeat.com

Blair William & Co. IL Sells 15,263 Shares of ResMed Inc. (NYSE:RMD)

March 29 at 5:56 AM | marketbeat.com

UniSuper Management Pty Ltd Acquires 2,138 Shares of ResMed Inc. (NYSE:RMD)

March 29 at 5:31 AM | marketbeat.com

Mitsubishi UFJ Trust & Banking Corp Buys 23,250 Shares of ResMed Inc. (NYSE:RMD)

March 29 at 4:54 AM | marketbeat.com

ResMed Inc. (NYSE:RMD) Shares Sold by American Century Companies Inc.

March 29 at 4:18 AM | marketbeat.com

Resmed drives awareness

March 28 at 3:41 PM | hmenews.com

EntryPoint Capital LLC Takes $347,000 Position in ResMed Inc. (NYSE:RMD)

March 28 at 4:57 AM | marketbeat.com

Prudential Financial Inc. Trims Stock Position in ResMed Inc. (NYSE:RMD)

March 28 at 4:50 AM | marketbeat.com

Corebridge Financial Inc. Raises Position in ResMed Inc. (NYSE:RMD)

March 28 at 4:49 AM | marketbeat.com

Analysts Set ResMed Inc. (NYSE:RMD) Price Target at $246.83

March 28 at 4:49 AM | americanbankingnews.com

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Takes Position in ResMed Inc. (NYSE:RMD)

March 27, 2025 | marketbeat.com

ResMed Inc. (NYSE:RMD) Shares Bought by UNIVEST FINANCIAL Corp

March 27, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
By Thomas Hughes | March 11, 2025
View NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
Is BigBear.ai's 25% Plunge a False Alarm or Fire Sale?
By Jeffrey Neal Johnson | March 7, 2025
View Is BigBear.ai's 25% Plunge a False Alarm or Fire Sale?
Cybersecurity Stocks Surge as $32B Deal Reshapes the Industry
By Gabriel Osorio-Mazilli | March 21, 2025
View Cybersecurity Stocks Surge as $32B Deal Reshapes the Industry
3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
By Thomas Hughes | March 3, 2025
View 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely

HOLX, EW, IDXX, and RMD Company Descriptions

Edwards Lifesciences NYSE:EW

$70.90 -0.29 (-0.41%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$70.92 +0.03 (+0.04%)

As of 03/28/2025 06:30 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Hologic NASDAQ:HOLX

$61.32 -1.00 (-1.60%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$61.32 0.00 (0.00%)

As of 03/28/2025 05:36 PM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

IDEXX Laboratories NASDAQ:IDXX

$415.87 -6.67 (-1.58%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$413.75 -2.12 (-0.51%)

As of 03/28/2025 06:34 PM Eastern

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

ResMed NYSE:RMD

$219.85 -2.77 (-1.24%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$219.87 +0.02 (+0.01%)

As of 03/28/2025 05:55 PM Eastern

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time